国际医药卫生导报
國際醫藥衛生導報
국제의약위생도보
INTERNATIONAL MEDICINE & HEALTH GUIDANCE NEWS
2014年
20期
3142-3144
,共3页
聚桂醇%硬化治疗%安全性
聚桂醇%硬化治療%安全性
취계순%경화치료%안전성
Lauromacrogol injection%Sclerotherapy%safety
目的 分析聚桂醇注射液在内镜下治疗食管静脉曲张破裂出血的有效性及安全性.方法 对我院166名食管静脉曲张患者接受内镜下聚桂醇注射液硬化治疗的疗效、术后并发症等进行统计分析,评估聚桂醇注射液在硬化治疗中的有效性及安全性.结果 聚桂醇注射液硬化治疗食管静脉曲张止血成功率为90.36%,再出血患者仅为17.88%,术后并发症主要是胸痛为主.结论 内镜下使用聚桂醇注射液治疗食管静脉曲张有较好疗效,安全性好,患者容易接受,值得推广应用.
目的 分析聚桂醇註射液在內鏡下治療食管靜脈麯張破裂齣血的有效性及安全性.方法 對我院166名食管靜脈麯張患者接受內鏡下聚桂醇註射液硬化治療的療效、術後併髮癥等進行統計分析,評估聚桂醇註射液在硬化治療中的有效性及安全性.結果 聚桂醇註射液硬化治療食管靜脈麯張止血成功率為90.36%,再齣血患者僅為17.88%,術後併髮癥主要是胸痛為主.結論 內鏡下使用聚桂醇註射液治療食管靜脈麯張有較好療效,安全性好,患者容易接受,值得推廣應用.
목적 분석취계순주사액재내경하치료식관정맥곡장파렬출혈적유효성급안전성.방법 대아원166명식관정맥곡장환자접수내경하취계순주사액경화치료적료효、술후병발증등진행통계분석,평고취계순주사액재경화치료중적유효성급안전성.결과 취계순주사액경화치료식관정맥곡장지혈성공솔위90.36%,재출혈환자부위17.88%,술후병발증주요시흉통위주.결론 내경하사용취계순주사액치료식관정맥곡장유교호료효,안전성호,환자용역접수,치득추엄응용.
Objective To analysis of the effectiveness and safety of lauromacrogol injection in the endoscopic treatment of esophageal varices bleeding.Methods The effectiveness and postoperative complications of 166 patients receiving endoscopic sclerotherapy of lauromacrogol injection in the treatment of esophageal varices at our hospital were statistically analyzed.The efficacy and safety were evaluated.Results The hemostasis rate of endoscopic sclerotherapy of lauromacrogol injection in the treatment of esophageal varices was 90.36%.Only 17.88% patients re-bled.Chest pain was the main postoperative complication.Conclusions Endoscopic sclerotherapy of lauromacrogol injection for esophageal varices under is effective and safe and could be easily accepted by the patients.It is worth being generalized.